Atlas Venture — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Chroma Medicine, Inc.Sep 2023SEC filingmedium confidence
Boston, US
Board seatKevin Bitterman· per SEC Form D · $135M raise · filed Sep 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.